1. Home
  2. YHC vs PPCB Comparison

YHC vs PPCB Comparison

Compare YHC & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

N/A

Current Price

$1.39

Market Cap

2.2M

ML Signal

N/A

Logo Propanc Biopharma Inc.

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.93

Market Cap

2.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
YHC
PPCB
Founded
2021
2007
Country
United States
Australia
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.6M
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
YHC
PPCB
Price
$1.39
$0.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
45.9K
3.3M
Earning Date
04-15-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
8.28
N/A
Revenue
$1,120,622.00
N/A
Revenue This Year
$1,267.57
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.17
N/A
Revenue Growth
86.42
N/A
52 Week Low
$0.02
$0.06
52 Week High
$2.72
$6.79

Technical Indicators

Market Signals
Indicator
YHC
PPCB
Relative Strength Index (RSI) 42.98 42.66
Support Level $0.77 $0.90
Resistance Level $2.20 $1.38
Average True Range (ATR) 0.10 0.29
MACD -0.04 -0.03
Stochastic Oscillator 17.31 0.47

Price Performance

Historical Comparison
YHC
PPCB

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: